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The term evidence-based medicine (EBM) was first used in
a paper published in JAMA in 1992 [1]. In the book
Evidence-based medicine: how to practice and teach EBM,
EBM was defined as the “conscientious, explicit, and
judicious use of current best evidence in making decisions
about the care of individual patients” [2]. This was not a
new concept at the time. Physicians caring for patients
before the era of EBM presumably also made use of the
best available evidence. What made EBM a new paradigm
for medical practice was the description of four steps that
physicians should follow in order to practice evidence-
based medicine: (1) physicians should formulate a specific
and clinically relevant question and then (2) quickly and
effectively search for the best available evidence. (3) Once
they have critically appraised the validity and utility of the
evidence, (4) they should apply the findings of their critical
appraisal in clinical practice.
The idea of EBM disseminated rapidly throughout the
world; new institutions were established, and specialized
EBM journals were launched. There are two reasons for
this rapid dissemination: first, the tremendous increase in
the number of published papers, and second, the decline in
trust toward ‘experts’ and authority. Up until half a century
ago, only a few clinical trials measuring clinically relevant
outcomes had been produced. Since then, more than
100,000 randomized controlled trials have been published;
approximately 12,000 were published in 2008 alone.
Furthermore, the results of several cohort, case-control,
and other types of studies lower on the EBM hierarchy have
been reported. It has become quite impossible for a
physician to identify all of the relevant papers for his or
her specialty, not to mention to read them, in order to keep
up to date. The intention of the founders of EBM was to
enable physicians to identify relevant research articles and
to critically appraise the original literature with the hope of
making them more independent of the opinions and beliefs
of the prevailing experts.
The rank and high standing of medical experts was
anathema to the founders of EBM. Medical experts are
those who state their beliefs and opinions at medical
conferences and in review articles. Among the weaknesses
that they may fall prey to are the selective citing of research
results, inappropriate judgments regarding the methodolog-
ical quality of cited papers, and the formulation of
conclusions and recommendations that are not supported
by the available evidence [3]. Furthermore, suspicions that
financial relationships between experts and pharmaceutical
companies might have an impact on the conclusions and
recommendations reached by experts is common and not
entirely unwarranted. Stelfox et al. showed that experts who
recommend calcium-channel antagonists for the treatment
of high blood pressure are significantly more likely than
neutral authors to have financial ties with manufacturers of
these drugs [4]. Not surprisingly, examples such as this
have led to an even greater loss of trust in experts.
One of the most important and sustainable effects of the
EBM initiative was, and still is, the advancement of
methods to synthesize the available evidence systematically
and transparently. The results of single studies are often
imprecise, and the results of different studies on the same
object may differ substantially. Systematic reviews and
meta-analyses allow entire bodies of evidence to be
assessed. The Cochrane Collaboration and independent
researchers working outside the Cochrane Collaboration
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deserve much credit for developing and critically improving
methods to synthesize evidence from different sources.
Today, meta-analyses are performed by combining data not
only at the level of study results, but also at the level of
individual patients. Network meta-analyses are a recent
advancement in the field; they assess the relative effective-
ness of different treatments that have not been compared
directly in randomized controlled trials [5]. Systematic
reviews are meant to support “busy clinicians seeking
bottom lines,” so that they will not have to rely upon
reviews by so-called experts or information sponsored by
manufacturers of drugs/medical devices and can find “brief
but valid summaries of best evidence” [2].
When we take a critical look at the promises made by
proponents of EBM, we see that they have only partly been
fulfilled. Clinicians and policy makers do not use system-
atic reviews as often as expected. Systematic reviews are
often too long and detailed for busy clinicians to read;
additionally, they do not provide the clinician with the
relevant information. A survey performed by Glasziou et al.
revealed that fewer than 15% of the systematic reviews
published in Evidence based medicine provided sufficient
information about the intervention to allow clinicians to
implement it [6]. The conclusions of systematic reviews
often state that the available evidence is inconclusive and
that further studies must be performed. This is good news
for researchers, but not very helpful for physicians caring
for patients. The following is a typical example: the authors
of a systematic review wanted to evaluate whether resection
of the colon should be done primarily or as a staged
procedure in patients with obstruction from left colorectal
carcinoma. The main result reported by the authors
reads “We identified 2,043 citations. One study for
potential inclusion was identified, but was then excluded.”
The conclusion was “ the limited number of identified
studies … do not allow a reliable assessment of the role of
either therapeutic strategy … it would appear advisable to
conduct high quality large scale RCT to establish which
treatment is more effective” [7].
Without a doubt, most researchers performing systematic
reviews search carefully for the relevant literature in
different databases, contact researchers to retrieve informa-
tion not reported in the published papers, and try to obtain
unpublished studies from drug and medical device compa-
nies. However, despite methodological advancements in
merging primary study results into systematic reviews,
major problems persist. Varying enrollment criteria in
primary studies, differences in the definition and assess-
ment of clinical outcomes, and the measurement of the
outcome at varying time points hamper the pooling of
different studies. The consequence is that even the results of
systematic reviews on one and the same topic may be
inconsistent.
This problem is exemplified in the article by Peterson
and Hodler in this journal on the use of therapeutic
injections for the spine and sacroiliac joints. A systematic
review evaluating the benefit of injections in the facet joints
of the lumbar spine concluded that there is moderate
evidence that this therapy is effective in providing pain
relief. Two other reviews came to the conclusion that there
is no strong evidence for or against the use of injection
therapy. Such inconsistencies are a matter of fact. For
physicians and policy makers, such conflicting results and
conclusions are not helpful; nor is the recommendation that
further studies should be done.
Therefore, the solution is to establish a knowledge base of
medicine from which physicians can draw the information
that they need to care for patients [8]. A collection of evidence
in the form of systematic reviews and the results of
randomized trials or other clinical studies may not be
sufficient. The crucial step is the transformation of evi-
dence—the results of research—into knowledge. This is a
task that should be undertaken by experts. Experts in a
clinical specialty or subspecialty, in cooperation with experts
in research methodology and statistics, would be competent
to establish this knowledge base.
A prevailing characteristic trait of the EBM movement is
the ambiguous and occasionally negative attitude toward
expert opinions. Various scales for grading the levels of
evidence have been developed and disseminated within the
past decade. To my knowledge, in all of them, expert
opinions lag behind single case reports in terms of
trustworthiness. According to the recommendations of the
Oxford Centre for Evidence-Based Medicine [9] regarding
studies of prognosis, the highest level of evidence is a
systematic review of randomized controlled trials, followed
by single randomized trials, and cohort and other study
designs. Expert opinions follow poor-quality cohort studies.
The categorization and grading of evidence levels is
based on study design, and experts do not belong in this
category. An expert should be a person of integrity with a
high degree of knowledge about a certain subject. Expert
opinions cannot be a substitute for the results of a
randomized controlled trial or other carefully planned and
executed studies, but expert knowledge is essential when an
entire body of evidence is being assessed and evidence, the
results of research, is being transformed to knowledge. The
result of this process would be the knowledge base of
medicine, which physicians could trust and rely upon.
Knowledge in this context is defined as the shared beliefs
of experts.
Carefully planned and executed primary studies and
systematic reviews are a first and essential step in establish-
ing the knowledge base, but the process should not stop
there. I propose that a panel of experts in a specific field,
for example, diagnostic and therapeutic injections for
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patients with joint and back pain, come together to
appraise, discuss, and weigh the available evidence and
then draw up a ‘shared expert opinion.’ The purpose of
such a panel would not be to reach consensus on the least
common denominator, and the desired result would not be a
recommendation for what physicians should do. The result
could be a publication, including a detailed description, as
specific as possible, about the consequences in terms of
probabilities. For example, the outcome of injections in the
sacro-iliac joint of patients with chronic low back pain
below L5 would be compared to the outcomes of other
treatment modalities. This panel would provide knowledge-
oriented guidance rather than action-oriented guidelines
telling physicians and/or patients what they should do.
Physicians would be able to provide patients with valuable
information, and patients would be empowered to make
informed decisions.
Specific considerations for further research could be an
additional achievement of the panel. An obvious difficulty
when one is evaluating the effect of treatment on patients
with low back pain concerns the question of which patients
to enroll in studies. In contrast with patients who have had a
myocardial infarction, many patients with low back pain
have structural or functional anomalies underlying their
symptoms that are unknown. Researchers are trying to
overcome this difficulty by identifying variables that will
allow them to characterize these patients more accurately.
One treatment modality is an injection of analgesics into the
sacro-iliac joint or the surrounding structures in patients
with chronic low back pain below L5. The rationale is that
patients for whom pain decreases or disappears after the
analgesics injection have a higher probability of benefiting
from a therapeutic injection with steroids into the same
joint. Comparisons of different studies reveal that no
uniform technique was used and that different criteria were
applied to judge whether pain arose from the sacro-iliac
joint or elsewhere [10]. Therefore, those patients that were
included in the studies assessing the effect of therapeutic
injections with steroids might have differed with respect to
the underlying causes of low back pain. Shared recom-
mendations from experts regarding which test to utilize and
how to measure the effect of diagnostic injections would be
helpful for directing the planning and execution of further
trials. In future systematic reviews, this will make it easier
for study results to be compared and pooled.
Evidence is not synonymous with knowledge. Evidence
is the result of research, and knowledge is, when based on
reliable evidence, “shared expert beliefs.” After the shun-
ning of experts and authorities by the EBM movement, it is
time to allow experts—impartial, objective persons of
integrity with a high degree of knowledge in their field—
to return and establish the knowledge base of medicine.
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